Ignite Creation Date:
2024-05-06 @ 7:05 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05891769
Status:
RECRUITING
Last Update Posted:
2024-04-17
First Post:
2023-05-26
Brief Title:
99mTc Sestamibi SPECTCT vs 18F Fluorocholine PETCT
Sponsor:
Andrei Iagaru
Organization:
Stanford University
Study Overview
Official Title:
Evaluation of Patients With Suspected Parathyroid Adenoma and Negative or Equivocal 99mTc Sestamibi SPECTCT Using 18F Fluorocholine PETCT
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
18FCH
Brief Summary:
This study proposes the use of a well-established PET isotope Fluorine-18 18F bound to Choline for a prospective single-center single-arm study for participants with suspected parathyroid adenoma and negative or equivocal standard of care 99mTc Sestamibi SPECTCT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None